GoLIMS Technology Speeds and Safeguards Alltech’s Global Research
News Mar 03, 2013
With three major bioscience centers on two continents and 150 researchers globally, data sharing could easily prove to be a challenge for Alltech. However, a new technology partnership between the top ten animal health company and GoLIMS utilizes a cloud storage system and electronic laboratory notebook platform to establish a secure and collaborative data collection globally.
Alltech has deployed GoLIMS across its research divisions to streamline data capture, eliminate data silos, facilitate collaboration and information sharing, reduce complexity and accelerate its research. As opposed to traditional methods of data sharing, global collaboration is enhanced through the instantaneous nature of the cloud storage system and electronic laboratory notebook. Meanwhile, data transcription errors are mitigated since the data is entered directly into the system at first transcription.
“We have implemented GoLIMS technology throughout our global research network because of its extensive capability to perform research management in a traceable and compliant manner,” said Dr. Karl Dawson, chief scientific officer at Alltech. “GoLIMS establishes an infrastructure for centralized research data management, enabling our researchers to easily collaborate and protect sensitive intellectual capital.”
“Through our expanding partnership, we are confident Alltech will continue to realize the same high-value use of the GoLIMS platform as that of our other clients, including increased collaboration on research processes, reduced R&D costs through improved efficiencies, and enhanced protection of vital intellectual property,” said Chad Gregory, CEO of GoLIMS.
GoLIMS offers a wide variety of services to create an all-encompassing home for research data. The cloud-based application’s suite of capabilities includes project management, electronic notebooking, inventory control and online file storage. Alltech’s use of GoLIMS will help safeguard future intellectual properly as well as promote collaboration and productivity amongst its global research groups.
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE
Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive CancersNews
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.READ MORE
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE